SCHEMBL18849152

SCHEMBL18849152

CN1CCCN(C2=CC=CCC2)CC1

nearest known ligand 0.40

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 2/20 0.40
CHKA P35790 2/20 0.38
LMNA P02545 1/20 0.36
HRH4 Q9H3N8 4/20 0.33
ROCK2 O75116 4/20 0.33
ROCK1 Q13464 4/20 0.33
HTR3A P46098 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29980540 0.93 ADRA2C (0.34) HRH4HTR3A
SCHEMBL18639230 0.86 ADRA2C (0.32) HRH4
SCHEMBL17934702 0.81
SCHEMBL18052758 0.75 ALDH1A1 (0.38) HRH4HTR3A
SCHEMBL20780839 0.74
SCHEMBL12663101 0.74 CHRNA7 (0.42) LMNA
SCHEMBL31696522 0.74 ALDH1A1 (0.33)
SCHEMBL13650809 0.71 ALDH1A1 (0.38) NCF1LMNAHTR3A
SCHEMBL30425332 0.71 LMNA (0.36) LMNA
SCHEMBL19120784 0.70 MAPT (0.46) LMNAHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017076968-A1 COMPOUNDS FOR TREATMENT OF HYPOPROLIFERATIVE DISORDERS LU LICENSE AB (SE) 2017-05-11 WO disclosed